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ABSTRACT 
Liver cirrhosis is the outcome of chronic liver injury. The current study aimed to investigate the therapeutic ef-
fect of undifferentiated mesenchymal stem cells versus in vitro partially differentiated mesenchymal stem cells 
on liver cirrhosis and hepatic encephalopathy. 50 adult male albino rats constituted the animal model and were 
divided into the following groups: control, thioacetamide, undifferentiated mesenchymal stem cells and hepato-
cyte growth factor-differentiated mesenchymal stem cells groups. Cognitive assessment was achieved by open 
field test and Y-maze task. We measured serum alanine aminotransferase, albumin and transforming growth fac-
tor-beta1, gene expression of α-smooth muscle actin, matrix metalloprotein-2, its tissue inhibitor and apoptotic 
markers: Bax and Bcl2, brain glial fibrillary acidic protein, synaptophysin, and dopaminergic receptors.  
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INTRODUCTION 
Liver cirrhosis represents the final patho-
logic outcome for the majority of chronic 
liver diseases (Salama et al., 2014). Due to 
the functional overcapacity of liver, fibrosis, 
and even cirrhosis are frequently asympto-
matic until complicated by life-threatening 
events such as variceal hemorrhage, sponta-
neous bacterial peritonitis and hepatic en-
cephalopathy (HE) (Schuppan & Afdhal, 
2008).  
Despite the improvements in the man-
agement of liver cirrhosis, the overall out-
come of the disease remains unsatisfactory 
(Bai et al., 2014). Current treatment for liver 
cirrhosis is to prevent further damage of the 
functional hepatocytes as well as liver trans-
plantation. Although a significant advance in 
liver transplantation has taken place, still it 
has several limitations (Singal and Duchini, 
2011). Alternative therapeutic approaches 
through stem cells may become other options 
(Chang et al., 2009). 
Stem cells are undifferentiated highly 
specialized cells, having the capacity to re-
new itself and are capable of dividing to 
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grow different cell types (Ding et al., 2011). 
Among the various types of stem cells, mes-
enchymal stem cells (MSCs) in particular 
have been thought as a promising source of 
stem cells in regenerative medicine (Shetty 
et al., 2014) because of their high capability 
for self-renewal and differentiation without 
ethical or tumorigenic problems (Jang et al., 
2014). However, there are still several chal-
lenges including conflicting data regarding 
MSCs engraftment in the liver and their 
long-term efficacy, the potential risk of ma-
lignant transformation and unwanted mesen-
chymal lineages differentiation in vivo which 
limit their ability to be used as a mainstream 
treatment approach for liver regeneration 
(Volarevic et al., 2014). 
Different studies suggested that injured 
liver tissue secretes various paracrine factors 
and chemoattractive agents that have a re-
markable role in stem cell recruitment, hom-
ing process (Lysy et al., 2008). Also, injured 
liver secretes enhancers of hepatic MSCs dif-
ferentiation such as hepatocyte growth factor 
(HGF), fibroblastic growth factor (FGF) 
(Ishii et al., 2008). 
Hepatic encephalopathy (HE) is a com-
mon complication in patients with liver cir-
rhosis. HE not only results in a diminished 
quality of life but confers a poorer prognosis. 
The liver cirrhosis in patients without clini-
cal symptoms of HE may show mild cogni-
tive impairment (Romero-Gomez et al., 
2007). In severe cases, it can even lead to 
coma or death with cerebral edema (Poh and 
Chang, 2012). 
Cognitive studies in animal models of 
HE demonstrated that there is impairment in 
exploratory behavior (Leke et al., 2012), spa-
tial and non-spatial memory (Nasehi et al., 
2013).  
Basal Ganglia (BG) is a key player in a 
variety of crucial brain functions including 
reward-based learning, exploratory behavior, 
action selection, action-gating, motor prepa-
ration and timing (Chakravarthy et al., 
2010). A common thread that runs through 
all the roles of the BG is the involvement of 
dopamine (DA) in regulating the activity of 
its different nuclei (Kalva et al., 2012). 
The aim of the work was to evaluate the 
therapeutic effect of undifferentiated and 
hepatocytic in vitro partially differentiated 
mesenchymal stem cells on thioacetamide 
(TAA) induced liver cirrhosis and HE as a 
complication as well as their possible thera-
peutic mechanisms. 
 
MATERIALS AND METHODS 
The Scientific and Ethical Committee of 
Physiology Department, Faculty of Medi-
cine, Cairo University approved the experi-
mental procedures, animal handling, sam-
pling, and scarification. 
 
Experimental animals 
50 adult male albino rats weighing 150-
200 gram constituted the animal models for 
this work, housed 2 or 3 per cage and accli-
matised for two weeks before the study. We 
kept all animals under the same environmen-
tal conditions at room temperature with free 
access to water and rat chow all through the 
work. We used ten rats for isolation of bone 
marrow-derived MSCs, and divided the re-
maining 40 animals into the following four 
groups (10 rats/group): 
Control Group: healthy male rats (sa-
line injected group) 
TAA Group: in this group, liver cirrho-
sis was induced by intraperitoneal injection 
of 200 mg/kg TAA three times weekly for 12 
weeks (Poonkhum et al., 2011) followed by 
single IV injection of 1 cc phosphate buffer 
saline 
Undifferentiated MSCs Group: in this 
group liver cirrhosis was induced as in the 
TAA group, followed by single IV injection 
of undifferentiated MSCs in the rats' tail vein 
(3 million cells in 1 cc phosphate buffer sa-
line/ rat) (Zhang et al., 2010) 
Differentiated MSCs Group: in this 
group liver cirrhosis was also induced as in 
the TAA group followed by single IV injec-
tion of partially differentiated MSCs in the 
rats’ tail vein (3 million cells in 1 cc phos-
phate buffer saline/rat) (Zhang et al., 2010). 
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Hepatocytic differentiation 
MSCs were induced to differentiate into 
hepatocyte-like cells using HGF (R&D Sys-
tems) and fibroblast growth factor (FGF-4, 
R&D Systems). Passage 5 cells were cul-
tured in the presence of liver-specific growth 
factors and were added sequentially (days 0–
3: basal medium + 10 ng/mL FGF-4; days 3–
6: basal medium + 20 ng/mL HGF; from day 
6 on: basal medium 20 + ng/mL HGF, 
1×ITS, and 20 µg/L dex). We changed dif-
ferentiation media every three days. Differ-
entiation was confirmed by morphology 
(Figure 1) and by detection of albumin and 
α-fetoprotein gene expression in cells as fol-
lows: 
 
Figure 1: MSC in culture: A: spindle-shaped 
(undifferentiated); B: rounded shaped (differenti-
ated) 
 
PCR detection of human albumin and  
α-fetoprotein gene expression 
Total RNA was extracted from cultured 
cells using RNeasy purification reagent (Qi-
agen, Valencia, CA). We generated cDNA 
from 5 μg of total RNA extracted with 1 μl 
(20 picomoles) antisense primer and 0.8 μl 
superscript AMV reverse transcriptase for 60 
min at 37 °C. For PCR, we incubated 4 μl 
cDNA with 30.5 μl water, 4 μl 25 
mMMgCl2, 1 μl dNTPs (10 mM), 5 μl 10× 
PCR buffer, 0.5 μl (2.5 U) Taq polymerase 
and 2.5 μl of each primer containing 
10 picomoles. We used the following oligo-
nucleotide primers: 
Albumin (Forward, 5'-GGCAGGGCT 
CAGTCAGTAATGA-3'; Reverse, 5'-AGG 
CCTACCCCAGCCAGTAG-3'), 
α-fetoprotein (Forward, 5'-TCCTGAAT 
GGGAGAGGTCC-3'; Reverse, 5'-TCTTGG 
CCAAAGGAGACG-3'),  
We performed amplification reactions at 
94 °C for 30 seconds, 55 °C for 30 seconds, 
and 72 °C for 60 seconds for 30 cycles. 
After 30 days of MSCs injection (Piryaei 
et al., 2011) we assessed the following pa-
rameters: 
I: Behavioral assessment: we per-
formed cognitive tests twice; before induc-
tion of liver cirrhosis and just before scarifi-
cation; using Y-maze (Arai et al., 2001) and 
open field tasks (Baykara et al., 2012) to 
evaluate spatial working memory, locomo-
tion, and anxiety.  
Blood samples were collected from retro-
orbital sinuses for assessment of liver func-
tions by measurement of serum albumin, al-
anine aminotransferase (ALT), ammonia and 
transforming growth factor beta1 (TGF-β1). 
Animals then were sacrificed, liver and brain 
samples obtained for gene expression and 
histopathological workup. 
II: Biochemical analysis: Serum ALT 
and albumin levels were assessed by kits 
from BioAssay Systems Company (Califor-
nia, USA) using the colorimetric method. 
Ammonia was enzymatically determined in 
serum using Ammonia Assay Kit (Sigma-
Aldrich, Spruce St., St Louis, USA). Serum 
TGF-β1 level was assessed by enzyme-
linked immunosorbent assay (ELISA) (R&D 
Systems, Inc., USA) according to manufac-
turer instructions. 
Gene expression of α-SMA, MMP-2, 
TIMP-2, Bax, Bcl2 in liver tissue and hippo-
campal glial fibrillary acidic protein (GFAP), 
synaptophysin and basal ganglia dopamine 
(D1) receptors by quantitative real-time po-
lymerase chain reaction (qRT-PCR) as fol-
lows: 
A: RNA extraction and cDNA synthesis 
Total RNA was extracted from liver and 
brain tissue homogenate using SV Total 
RNA Isolation system (Promega, Madison, 
WI, USA) according to manufacturer's proto-
col. The yield of total RNA obtained was de-
termined spectrophotometrically at 260 nm. 
We used the total RNA (0.5–2 μg) for cDNA 
conversion through cDNA reverse transcrip-
tion kit (K1621, Fermentas, USA). 
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B: Real-time PCR 
Real-time qPCR amplification and analy-
sis were performed using an Applied Biosys-
tem with software version 3.1 (StepOne™, 
USA) with the primers shown in Table 1. 
Every reaction consisted of 5 μl cDNA, 
1 μl of each primer (400 nM) and 12.5 μl re-
action buffers (Platinum SYBR Green) (total 
reaction volume 25 μl). Real-time PCR cy-
cles consisted of 2 min at 50 °C, for poly-
merase activation, 40 cycles of 95 °C for 
15 s and 60 °C for 1 min and 72 °C for 
1 min. We normalised the level of expression 
of each target gene was about the expression 
of GAPDH mRNA in that sample using the 
ΔCt method. Relative differences in gene 
expression between groups were determined 
using the comparative Ct (ΔΔCt) method and 
we calculated fold expression as 2−ΔΔCt, 
where ΔΔCt represents ΔCt values normal-
ised about the mean ΔCt of control samples. 
 
III: Histological examination and de-
tection of MSCs homing: Liver and brain 
tissues were processed and fixed in 10 % 
formalin solution for 24 hours then embed-
ded in paraffin. The paraffin blocks were se-
rially sectioned at 5 μm thickness then 
stained with routine hematoxylin-eosin 
(H&E) for liver and brain and Masson's tri-
chrome (MT) stain (Bancroft, 2008) for as-
sessment of liver fibrosis. We sectioned 
brains at the levels of hippocampus and basal 
ganglia.  
Each liver specimen was evaluated for 
the extent of fibrosis using the criteria of 
Ishak et al. (1995) and was calculated using 
Leica Qwin 500 Image Analyzer. Five repre-
sentative sections were examined for each 
slide and area percentage was calculated by 
the image analysis system. The image analy-
sis system consists of a microscope (LEICA 
DMLB) equipped with a colored digital 
camera (JVC COLOR VIDEO CAMERA 
TK- C1380 ½ INCH CCD), linked to a com-
puter via an image-capturing board, having 
the LEICA software package. We analyzed 
The captured images through an intelligent 
interactive image analysis procedure (Leica 
Qwin 500, version 23, Leica Microsystems 
Imaging Solutions 1993- 1998) over Mi-
crosoft Windows 98, 2nd ed. To capture the 
widest area of the tissue, we used a 5× mag-
nification objective digitised following inter-
active light intensity equilibration, and ana-
lysed as RGB 24-bit images. The stained 
section represented fibrosis as blue/green 
and the parenchyma as red. The total area of 
 
Table 1: The oligonucleotide primers sequence of the studied genes (in vivo) 
Parameter Primer sequence 
α-SMA 
 
Forward primer: 5′ - GTT TGA GAC CTT CAA TGT CCC -3′ 
Reverse primer: 5′-CGA TCT CAC GCT CAG CAG -3′ 
MMP-2 Forward primer: 5- ATCTGGTGTCTCCCTTACGG 3 
Reverse primer: 5- GTGCAGTGATCCGACAAC -3 
TIMP-2 Forward primer: 5′-AGGGCCAAAGCAGTGAGCGAGAA-3′ 
Reverse primer:  5′-CCGCCTTCCCTGCAATTAGATATTC- 3′ 
BAX Forward primer: 5′- GTTGCCCTCTTCTACTTTG - 3′ 
Reverse primer: 5′- AGCCACCCTGGTCTTG - 3′ 
Bcl2 Forward primer: 5′ - CTGAGCTGACCTTGGAGC-3′ 
Reverse primer: 5′-GACTCCAGCCACAAAGATG-3′ 
GFAP Forward primer: 5′- GCTTACGGTGGGATTGCATT - 3′  
Reverse primer: 5′- TTATGGTGCCATGGGTGATG - 3′   
Synaptophysin Forward primer: 5′ - TGG GGT TCA GGG ATG ATC TA -3′  
Reverse primer: 5′-GCT TTC CCC ACA TTA CCT CA3′ 
Dopamine receptor 1 Forward primer: 5′- CAT CCCATT CGG CAG TTT TCA A - 3′ 
Reverse primer: 5′- TGG GTG TCT CAA GGC AGT GTC T -3′ 
EXCLI Journal 2016;15:652-670 – ISSN 1611-2156 
Received: September 19, 2016, accepted: October 31, 2016, published: November 07, 2016 
 
 
656 
the section was the sum of all microscopic 
fields including parenchyma and fibrosis. 
We excluded elements of the liver capsule 
from the computations.  
For detection of cell homing, sections 
were cut at 4 μm and were examined un-
stained under the inverted fluorescent micro-
scope to detect cells stained with PKH26 dye 
to ensure homing and trace the injected cells 
in liver and brain tissue. 
IV: Statistical analysis: Data was ana-
lysed using the statistical package SPSS ver-
sion 21. Data was summarised using mean 
and standard deviation for quantitative vari-
ables and frequencies (number of cases) and 
relative frequencies (percentages) for cate-
gorical variables. Comparisons between 
groups were made using analysis of variance 
(ANOVA) with multiple comparisons, Bon-
ferroni post hoc test in normally distributed 
quantitative variables and Kruskal-Wallis 
test with Mann-Whitney test for non-nor-
mally distributed variables (Chan, 2003a).  
For comparing categorical data, Chi-
square (2) test was performed (Chan, 
2003b). P-values less than 0.05 were consid-
ered as statistically significant. 
RESULTS 
I: Cognitive and behavioral results: As 
shown in Table 2: The alternation score 
showed a significant (p<0.05) decrease in the 
TAA group compared to the control group. 
After MSCs treatment it increased signifi-
cantly (p<0.05) only in the differentiated 
MSCs group compared to the TAA group. 
However; there is no significant difference 
between the two MSCs treated groups. 
The number of central square entries and 
center square duration in open field task 
showed a significant (p<0.05) decrease while 
the frequencies of freezing, stretch and defe-
cation increased significantly (p<0.05) in the 
TAA group compared to the control group. 
Frequencies of stretch and defecation de-
creased significantly (p<0.05) in the differ-
entiated MSCs group only compared to the 
TAA group. Although the frequency of 
grooming didn't increase significantly in the 
TAA group compared to the control group, 
yet it decreased significantly (p<0.05) also in 
the differentiated MSCs group only when 
compared to the TAA group. These results 
indicate a state of increased anxiety in the 
 
 
Table 2: Comparison of the performance in Y-Maze and open field tests in the studied groups at the 
end of the work 
Parameter 
Groups 
Control 
Group 
(n=10) 
TAA 
Group 
(n=10) 
Undifferentiated 
MSCs Group 
(n=10) 
Differentiated 
MSCs Group 
(n=10) 
Y-Task Alternation score (%) 44.02±9.3 22.41±12.76* 31.53±10.74 40.92±15.49# 
 
Number of Center 
Square Entries 4.5±3.47 0.9±0.74* 1.6±2.22 3.5±2.99 
Center Square  
Duration 26.8±20.17 3.1±2.6* 6.9±5.51* 11.8±10.69* 
Rearing frequency 5.9±2.88 10.10±5.74 9±4.99 6±4.88 
Grooming frequency 3.9±1.73 6.2±3.97 5.1±4.43 1.9±0.99# 
Freezing frequency 4.5±3.21 8.4±2.55* 7±4 6.8±1.03 
Stretch frequency 0.5±0.53 1.5±1.08* 0.9±0.99 0# 
Defecation  
(number of boils) 1.9±1.97 5.2±1.75* 3.7±1.57 2.7±2.11
# 
TAA: thioacetamide; MSCs: Mesenchymal stem cells; Values are represented as Mean±SD 
*: Statistically significant compared to corresponding value in control group (p<0.05) 
#: Statistically significant compared to corresponding value in TAA group (p<0.05) 
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animals belonging to the TAA group, and 
this anxiety decreased to some extent after 
MSCs treatment only in the differentiated 
MSCs group. 
 
II: Biochemical results: Table 3 shows 
marked deterioration of liver functions in the 
TAA group in the form of a significant in-
crease in serum ALT level, ammonia and 
TGF-β1 (p<0.05) and a significant decrease 
in serum albumin level (p<0.05) when com-
pared to the control. The groups treated with 
both undifferentiated, and differentiated stem 
cells showed improvement in the form of 
significant decrease of serum ALT, ammo-
nia, and the TGF-β1 and significant increase 
of serum albumin compared to TAA group 
with better outcome in differentiated than the 
undifferentiated MSCs group. 
Measurement of liver tissue parameters 
shown in Table 4 revealed a significant in-
crease in the relative expression of α-SMA 
after 12 weeks of TAA injection (p<0.05) 
when compared to the control group. Then it 
decreased significantly in undifferentiated 
and differentiated MSCs groups (p<0.05) 
when compared to the TAA group but it is 
still significantly (p<0.05) higher than its 
corresponding value in the control group. 
There is a significant decrease in relative 
expression of MMP-2 (p<0.05) and on the 
contrary significant increase in relative ex-
pression of its inhibitor TIMP-2 (p<0.05) 
which resulted in significant decrease in the 
ratio between them (p<0.05) in the TAA 
group when compared to the control group. 
This effect opposed after MSCs treatment as 
denoted by the significant increase in MMP-
2 relative expression (p<0.05) and decrease 
in its inhibitor (p<0.05) in both undifferenti-
ated and differentiated MSCs groups when 
compared to the TAA group. As a result 
MMP-2/TIMP-2 ratio also increased in both 
groups, but this increase was significant only 
in differentiated MSCs group (p<0.05) and 
not in the undifferentiated MSCs group when 
compared to the TAA group. 
A significant increase in relative expres-
sion of Bax (p<0.05) and a decrease in rela-
tive expression of Bcl2 (p<0.05) that led to 
an increase in the ratio between them 
(p<0.05) in the TAA group compared to the 
control group. These results opposed in 
MSCs treated groups in the form of a signifi-
cant decrease in relative expression of Bax 
and Bax/Bcl2 ratio (p<0.05) and a significant 
increase in relative expression of Bcl2 
(p<0.05) compared to the TAA group. In the 
differentiated MSCs group, relative expres-
sion of Bax is significantly lower (p<0.05) 
and relative expression Bcl2 is significantly 
higher (p<0.05) than their corresponding 
values in the undifferentiated MSCs group. 
On the other hand, results of Bax/Bcl2 ratio 
show no significant difference between the 
two MSCs treated groups and also no signif-
icant difference between either of them when 
compared to the control group. 
 
 
Table 3: Serum markers of liver function in the studied groups 
 Control 
Group 
(n=10) 
TAA 
Group 
(n=10) 
Undifferentiated  
MSCs Group 
(n=10) 
Differentiated  
MSCs Group 
(n=10) 
ALT (U/L) 19.98±2.41 76.42±6.35* 33.49±3.80*# 28.64±5.58*# 
Albumin (g/dl) 5.16±0.40 1.52±0.42* 2.93±0.55*# 3.94±0.58*#$ 
Ammonia (μg/dL) 11.52± 3.01 79.15± 10.73* 42.46± 7.39*# 38.2±9.05*# 
TGF-β1 (pg/ml) 30.81±3.50 109.82±6.83* 73.75±10.74*# 51.01±5.17*#$ 
TAA: thioacetamide; MSCs: mesenchymal stem cells; ALT: alanine amino-transferase; TGF-β1: transforming growth factor-β1.  
Values are represented as Mean ± SD. 
*: Statistically significant compared to corresponding value in control group (p<0.05) 
#: Statistically significant compared to corresponding value in TAA group (p<0.05) 
$: Statistically significant compared to corresponding value in Naïve MSCs group (p<0.05) 
Parameter 
Group 
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Table 4: Measured hepatic parameters by gene expression in the studied groups 
 Control 
Group 
(n=10) 
TAA 
Group 
(n=10) 
Undifferentiat-
ed MSCs 
Group 
(n=10) 
Differentiated  
MSCs Group 
(n=10) 
Relative expression of 
α-SMA 0.12±0.03 1.09±0.14* 0.43±0.15*
# 0.30±0.13*# 
Relative expression of 
MMP2 11.79±2.01 2.11±1.01* 7.61±1.10*
# 8.77±1.11*# 
Relative expression of 
TIMP2 1.14±0.16 11.07±1.44* 5.94±1.13*
# 2.97±1.40*#$ 
MMP2/TIMP2 ratio 10.62±2.65 0.19±0.08* 1.31±0.27* 3.48±1.30*#$ 
Relative expression of Bax 1.08±0.23 11.90±3.48* 5.02±1.96*# 2.23±0.76#$ 
Relative expression of Bcl2 11.09±1.88 1.36±0.42* 6.33±0.95*# 8.97±1.22*#$ 
Bax/Bcl2 ratio 0.10±0.03 9.58±4.40* 0.81±0.34# 0.26±0.10# 
TAA: thioacetamide; MSCs: Mesenchymal stem cells; α-SMA: α-smooth muscle actin; MMP2: Matrix metalloproteinase 2; 
TIMP2: tissue inhibitor of matrix metalloproteinase 2; Bcl2: B cell lymphoma 2; Bax: Bcl2 associated x protein. 
Values are represented as Mean ± SD. 
*: Statistically significant compared to corresponding value in control group (p<0.05) 
#: Statistically significant compared to corresponding value in TAA group (p<0.05) 
$: Statistically significant compared to corresponding value in Naïve MSCs group (p<0.05) 
 
 
Results of brain tissue parameters are 
shown in Table 5. There was a significant 
decrease (p<0.05) in the relative expression 
of both synaptic plasticity markers (GFAP 
and synaptophysin) and basal ganglia dopa-
mine (D1) receptors in the TAA group com-
pared to the control group. There was a sig-
nificant increase (p<0.05) in the relative ex-
pression of the three parameters after MSCs 
treatment in both differentiated and undiffer-
entiated MSCs groups when compared to the 
TAA group, without any significant differ-
ence between these two MSCs groups.  
 
III: Detection of MSCs homing: As 
seen in Figure 2 the red fluorescence detect-
ed differentiated (I) and undifferentiated (II) 
MSCs groups in liver (A&C) and brain 
(B&D) tissues, which indicate homing of 
PKH26 labelled differentiated and undiffer-
entiated MSCs respectively. 
 
IV: Histological results:  
A: Liver tissue histopathological  
examination 
As shown in Figure 3, in the control 
group the liver sections have typically ap-
pearing hepatocytes (H) running in normal 
thin trabeculae, portal tract area (P) no fibro-
sis deposition. TAA group showed fibrous 
expanded portal areas with septa, early nodu-
lar formation, apoptotic hepatocytes, marked 
inflammatory cell exudates (I), and prolifer-
ating bile ducts (arrows) due to the early cir-
rhotic changes. The undifferentiated MSCs 
group there was relative in the form of ex-
pansion of the portal tract (P) by moderate 
inflammatory cells (I), the hepatocytes ap-
pear irritated with vesicular nuclei. The dif-
ferentiated MSCs group shows a nearly nor-
mal appearance of hepatocytes, with the por-
tal tracts (P) free of fibrosis or inflammation 
denoting a marked improvement in the dif-
ferentiated MSCs group. 
In liver sections stained with MT (Figure 
4) there is a typical portal tract area contain-
ing blood vessel and bile duct with no portal 
fibrosis in the control group. In TAA group 
there was expanded portal tracts (P) with ex-
cessive fibrous tissue, septa (the arrows), and 
early nodular formation (N). The undifferen-
tiated MSCs group showed moderate expan-
sion of the portal area (P) by fibrous deposi-
tion with few septa formation (the arrows) 
denoting relative regression of cirrhosis ob-
Parameter 
Group 
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served in the TAA group after treatment with 
undifferentiated MSCs. 
Furthermore, we measured the % of fi-
brosis (Table 6) that showed a significant in-
crease (p<. 0.05) in the percentage of fibrosis 
area in the TAA group when compared to the 
control group. A significant decrease 
(p<0.05) in the percentage of fibrosis area in 
MSCs treated groups as compared to the 
TAA group. This decrease is more promi-
nent in the differentiated MSCs group as the 
percentage of fibrosis area in this group is 
significantly lower (p<0.05) than that of the 
undifferentiated MSCs group. These results 
were confirmed also by the increase in Ishak 
score from 0 in the control group to 5 in the 
TAA group, followed by its regression to 3 
and even 1 in the undifferentiated and differ-
entiated MSCs groups respectively. 
 
Table 5: Measured brain parameters by gene expression in the studied groups 
 Control 
Group 
(n=10) 
TAA Group 
(n=10) 
Undifferentiated 
MSCs Group 
(n=10) 
Differentiated 
MSCs Group 
(n=10) 
Relative expression of  
hippocampal GFAP 1.20±0.30 0.17±0.05* 0.61±0.22*
# 0.77±0.13*# 
Relative expression of  
hippocampal synaptophysin 1.32±0.39 0.16±0.09* 0.54±0.17*
# 0.72±0.18*# 
Relative expression of basal  
ganglia dopamine (D1)  
receptors 
10.18±0.95 1.85±0.52* 6.12±1.91*# 7.57±1.24*# 
TAA: thioacetamide; MSCs: mesenchymal stem cells; GFAP: glial fibrillary acidic protein. 
Values are represented as Mean ± SD 
*: Statistically significant compared to corresponding value in control group (p<0.05) 
#: Statistically significant compared to corresponding value in TAA group (p<0.05) 
 
 
 
Figure 2: Detection of MCSs homing into liver and brain: I: The presence of red fluorescent indicates 
homing of differentiated cells into liver (A) and brain (B) tissue; II: The presence of red fluorescent in-
dicate homing of undifferentiated cells into liver (C) and brain (D) tissue. 
Parameter 
Group 
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Figure 3: Photomicrograph of the liver sections stained by H&E (X400): A= Control, B= TAA group, 
C=u ndifferentiated MSCs group, D= differentiated MSCs group 
 
Figure 4: Photomicrograph of the liver sections stained by MT (x400): A= Control, B= TAA group, C= 
undifferentiated MSCs group, D= differentiated MSCs group 
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Table 6: Percentage of fibrosis area in liver of the studied groups and Ishak score of each group 
 Control  
Group 
(n=10) 
TAA  
Group 
(n=10) 
Undifferentiated 
MSCs Group 
(n=10) 
Differentiated  
MSCs Group 
(n=10) 
Fibrosis area (%) 0 15.41±1.71* 8.003±2.09*# 3.99±1.49*#$ 
Ishak score  0 5 3 1 
*: Statistically significant compared to corresponding value in control group (p<0.05) 
#: Statistically significant compared to corresponding value in TAA group (p<0.05) 
$: Statistically significant compared to corresponding value in Naïve MSCs group (p<0.05) 
 
 
B: Brain tissue histopathological  
examination 
As seen in Figure 5 basal ganglia in con-
trol group showed normal appearance with 
vesicular nuclei and prominent nucleoli. The 
neuropil is fibrillary with no clumps or vac-
uoles. TAA group showed many scattered 
degenerating ganglion cells (the arrows) in 
the basal ganglia area, these appear shrunken 
with dense cytoplasm and inconspicuous nu-
clei. The neuropil shows areas of increased 
density, i.e., clumped (C) and foci of vacu-
olization (V). The undifferentiated MSCs 
group showed some scattered degenerating 
ganglion cells (arrows) in the basal ganglia 
area. They appear shrunken with dense cyto-
plasm and absent normal vesicular nuclei. 
The neuropil shows focal clumping (C). In 
differentiated MSCs group, there are occa-
sional degenerating ganglion cells (arrows), 
they appear shrunken with dense cytoplasm 
and inconspicuous nuclei. The neuropil is 
almost within normal, yet few dilated blood 
vessel are seen (star). 
Hippocampal examination (Figures 6 and 
7) showed a typical appearance of the neu-
rons of the granular layer of the hippocam-
pus (GL) and the molecular layer (ML) in 
the control group. The regular arrangement 
of the pyramidal cells (P) which appear with 
their vesicular cytoplasm and prominent nu-
clei and normal dendrites, the molecular lay-
er (M) showed a typical neurofibrillary pat-
tern and vascularity. 
TAA group showed many degenerating 
neurons in the granular cell area (GL), these 
neurons appear dark and shrunken (the ar-
rows). The molecular layer (ML) shows 
clumped neuropil which points to decreased 
connectivity. Congested blood vessels (V) 
denoting constant irritation and cell injury. 
There is extensive damage to the pyramidal 
cells with cell loss and disorganised cells (P), 
these cells appear degenerated, dark and 
shrunken. The molecular layer (M) showed 
vacuolization of the neuropil (arrows) and 
congested blood vessels (V). 
The undifferentiated MSCs group 
showed the persistence of some injury in the 
granular cells area (GL) of the hippocampus 
in the form of multiple congested blood ves-
sels (V) denoting increased blood flow. Also, 
the scattered degenerating neurons (arrows) 
which appear dark shrunken with focally 
vacuolated cytoplasm (less than in the TAA 
group). The molecular layer (ML) showed 
moderately thickened neuropil with some 
micro-cystifications pointing to decreased 
connectivity. There is scattered degenerating 
pyramidal neurons (arrows) appearing dark 
and shrunken, in contrast to the normal adja-
cent neurons (P) which have vesicular nuclei 
and prominent nuclei. The molecular layer 
(M) showed fine neuropil and congested 
blood vessels (V). 
The differentiated MSCs group showed 
the granular cell area of the hippocampus 
(GL) with only occasional degenerating neu-
rons (arrows) which appear dark and shrunk-
en in contrast to the normal neurons which 
have vesicular nuclei. The molecular layer 
(ML) contains few congested blood vessels 
(V) and mildly thickened neuropil with mild 
clumping. 
 
Parameter 
Group 
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Figure 5: Photomicrograph of the basal ganglia stained by H&E (X400): A= Control, B= TAA group, 
C= undifferentiated MSCs group, D= differentiated MSCs group 
 
Figure 6: Photomicrograph of granular and molecular layers of the CA1 region of the hippocampus 
stained by H&E (X400): A= Control, B= TAA group, C= undifferentiated MSCs group, D= differentiated 
MSCs group 
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Figure 7: Photomicrograph of the pyramidal layer of the CA1 region of the hippocampus stained by 
H&E (X400): A= Control, B= TAA group, C= undifferentiated MSCs group, D= differentiated MSCs 
group 
 
 
DISCUSSION 
MSCs have gained popularity for their 
potential as seed cells to treat various human 
diseases (Xu et al., 2012). In vitro hepatic 
differentiation of MSCs followed by their in 
vivo inoculation also proved its success in 
improving liver fibrosis in animal models 
(Zhao et al., 2012). 
TAA is known hepatotoxic, which pro-
duces hepatic necrosis and cirrhosis by oxi-
dative stress mediated acute hepatitis and in-
duces apoptosis of hepatocytes in the liver 
(Sun et al., 2000). We demonstrated hepato-
cytic apoptosis indicated by significant in-
crease in relative expression of pro-apoptotic 
marker Bax and a decrease in relative ex-
pression of anti-apoptotic marker Bcl2 which 
led finally to an increase in the ratio between 
them (Bax/Bcl2). Contradictory to our re-
sults, Salama et al. (2013) showed no signif-
icant difference of Bax between the cirrhosis 
group and the control group while the level 
of anti-apoptotic Bcl-2 showed a significant 
increase in the cirrhosis group compared 
with the control group and a significant de-
crease in the ratio between them in the cir-
rhosis group. Our histopathological results 
after TAA administration are consistent with 
Elhaggagy et al. (2014).  
HSC activation is considered the pivotal 
event in the development of liver cirrhosis 
(Lin et al., 2014) being the primary source of 
ECM (Hernandez-Gea and Friedman, 2011). 
When activated, HSCs differentiate into α-
SMA expressing myofibroblast-like cells ca-
pable of depositing ECM (Puche et al., 
2013). In our study, HSC activation was con-
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firmed by the significant increase in relative 
expression of α-SMA in liver tissue of TAA 
group when compared to the control group. 
These results are in agreement with those of 
Elhaggagy et al. (2014) who assessed α-
SMA immunohistochemically and found that 
it increased significantly in cirrhotic rats 
compared to healthy ones. 
The current study revealed a significant 
increase in serum TGF-β1 in TAA treated 
rats compared to control rats. This increase 
can be related to the TAA-induced oxidative 
action that directly activates HSCs convert-
ing them to myofibroblasts and indirectly 
causes damage and apoptosis of hepatocytes. 
The damaged hepatocytes activate KCs that 
together with apoptotic hepatocytes release 
TGF-β1; the major fibrogenic cytokine 
which is critical for activation of HSCs. 
Moreover; TGF-β1 together with deposited 
ECM have an antiproliferative and pro-
apoptotic effect on hepatocytes (Swaroop 
and Gowda, 2012). 
Progression of liver fibrosis depends on 
the rate of deposition and degradation of 
ECM which is controlled by MMPs and their 
tissue inhibitors (TIMPs). The balance be-
tween MMPs and TIMPs controls progres-
sion or regression of liver fibrosis (Park et 
al., 2010). This balance is qualified in exper-
imental studies by expressing it in the form 
of a ratio between MMP and its tissue inhibi-
tor TIMP (MMP/TIMP) (Yang et al., 2011). 
The current work showed a significant 
decrease in relative expression of MMP-2 
while the relative expression of TIMP-2 
showed a significant increase in the TAA 
group compared to the control group. This 
increase in TIMP-2 and the decline in MMP-
2 caused a marked drop in the ratio between 
them (MMP-2/TIMP-2). Our results agree 
with previous studies indicating that chronic 
liver damage usually favors fibrogenesis 
over fibrolysis (Park et al., 2010). In agree-
ment with our results, the work done by Ma-
dro et al. (2012) showed a significant de-
crease of serum MMP2 activity in stages B 
and C of alcoholic cirrhosis patients rather 
than early stages. HE is a serious complica-
tion of a fibrotic liver.  
HE is related to an accumulation of toxic 
metabolites in the brain, especially ammonia 
(Albrecht and Zielińska, 2014). TAA may 
induce encephalopathy by both direct and 
indirect mechanisms. Indirect mechanisms 
are mediated primarily by liver failure in-
duced hyperammonemia that causes brain 
edema, alterations in neurotransmission, oxi-
dative stress, mitochondrial dysfunction and 
neuronal death (Mladenović et al., 2012). 
TAA-induced hyperammonemia is evi-
denced in the current study, as there is a 
highly significant increase in serum level of 
ammonia in the TAA group compared to the 
control group. Our findings agree with the 
results obtained by Jayakumar et al. (2014) 
in which induction of liver cirrhosis and con-
sequently chronic HE by TAA resulted in 
significant elevation of blood and brain am-
monia.  
In the current study behavioral evaluation 
of our experimental animals by Y-maze and 
open field tasks revealed marked deteriora-
tion of the spatial memory and observable 
increased anxiety in the TAA group com-
pared to the control. The work done by Hos-
seini et al. (2013) was consistent with ours, 
as it denoted significant deterioration of spa-
tial memory with slight, insignificant im-
pairment of locomotor activity as assessed 
by open field task. 
Astrocytes are the primary neural cells 
involved in this pathogenesis of hyperam-
monemia induced HE (Jayakumar et al., 
2014). Astrocytic swelling may result from 
altered levels of expression of genes coding 
for proteins implicated in cell volume regula-
tion including GFAP. GFAP is a major pro-
tein of cytoskeletal network resulting in im-
pairment of visco-elastic properties of astro-
cytes facilitating their swelling (Bélanger et 
al., 2002). GFAP is also considered a param-
eter of astrocytic activity (Bernardi et al., 
2013). In the current work, we found a sig-
nificant decrease in the relative expression of 
hippocampal GFAP in the TAA group that 
denotes astrocytic swelling and dysfunction 
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which most probably was one of the reasons 
for the deterioration of cognitive and motor 
performance in this group.  
The hippocampus is brain region that 
critically is involved in the acquisition, per-
formance of spatial and non-spatial memory 
tasks (Bouton and Moody, 2004). In this 
study, examination of CA1 area of the hip-
pocampus in the TAA group revealed degen-
erating neurons in the granular cell area, 
vacuolization and clumped neuropil which 
points to decreased connectivity in the mo-
lecular layer and extensive damage to py-
ramidal cells with cell loss and disorganised 
cells in the pyramidal layer. This finding is 
in agreement with studies by Peeling et al. 
(1993) and Norton et al. (1997). 
Synaptophysin is an abundant integral 
membrane protein of pre-synaptic vesicles 
involved in the regulation of neurotransmit-
ter release and synaptic plasticity (Jayakumar 
et al., 2014). In this study, there was a signif-
icant decrease in relative expression of hip-
pocampal synaptophysin after induction of 
liver cirrhosis. This reduction of synaptophy-
sin expression most probably resulted in the 
behavioral changes which occurred in the 
TAA group. Our finding is concomitant with 
the work done by Jayakumar et al. (2014).  
Although the hippocampal glutaminergic 
system plays a critical role in synaptic plas-
ticity (Bear and Malenka, 1994), a signifi-
cant involvement of dopamine in synaptic 
plasticity has also been demonstrated. Alt-
hough multiple dopamine receptor subtypes 
contribute to different aspects of learning 
and memory, the D1 receptors seem to play a 
more prominent role (El-Ghundi et al., 
2007).  
Our results revealed a significant reduc-
tion of basal ganglia D1 receptors in the 
TAA group, which might be one of the 
mechanisms by which spatial memory dete-
rioration took place. The reduction of D1 re-
ceptors expression in the current work may 
be due to hyperammonemia which resulted 
from liver cirrhosis and caused NMDA re-
ceptors loss. We may propose that selective 
loss of NMDA receptors caused decreased 
relative expression of D1 receptors due to 
the interaction between dopaminergic and 
glutaminergic systems (Pei et al., 2004). 
Results of the current study also demon-
strated a significant increase in anxiogenic-
like behaviors in rats belonging to the TAA 
group compared to the control group. Dopa-
minergic systems are shown to play pivotal 
roles in the regulation of anxiety-like behav-
iors (Reza Zarrindast et al., 2013). Converse-
ly, we can conclude that dysfunctional do-
paminergic system due to either decreased 
expression of DA receptors or decreased DA 
itself most probably leads to increased anxie-
ty level.  
MSCs were administered as a single bo-
lus injection of 3 million cells/rat following 
TAA administration for 12 weeks. Homing 
of MSCs was confirmed one month after 
their injection by examination of liver and 
brain tissue under the inverted fluorescent 
microscope and detection of red fluorescence 
of PKH26 labelled cells. 
Homing and liver repopulation following 
MSCs transplantation triggered by liver 
damage. Different studies suggested that in-
jured liver tissue secretes various paracrine 
factors and chemoattractive agents that regu-
late homing process (Dalakas et al., 2005). 
Some of these growth factors released from 
damaged liver cells may also play a role in 
the enhancement of hepatic differentiation of 
MSCs including HGF (Ishii et al., 2008) and 
FGF (Berg et al., 2007). 
The results of our study revealed that 
both undifferentiated and partially hepato-
cytic differentiated MSC therapies elicited 
pronounced regression of liver cirrhosis and 
improvement in all studied parameters. This 
improvement was more marked in the differ-
entiated MSCs group. 
In the undifferentiated MSCs group, his-
topathological results revealed relative re-
gression of cirrhosis and improved liver cell 
injury while in the partially differentiated 
MSCs group, regression of cirrhosis was 
much clearer. This improvement was con-
firmed by significant regression of fibrosis 
staging and percentage of fibrosis areas es-
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pecially in the differentiated MSCs group 
when compared to the TAA group. These 
histopathological findings were concomitant 
with profound improvement in liver func-
tions following MSCs treatment, especially 
in differentiated MSCs group when com-
pared with TAA group. 
In an attempt to explain our results, we 
tried to analyse the impact of MSC therapy 
on the primary factors contributing to fibro-
genesis and the interaction between them. 
Hypotheses about the mechanism by which 
MSCs may contribute to liver regeneration in 
our study have included paracrine effects and 
transdifferentiation of MSCs into hepato-
cytes (Parekkadan et al., 2007a). 
The effect of MSCs on liver cirrhosis 
could be achieved by their inhibition of HSC 
activity and proliferation and downregulation 
of collagen gene expression (Parekkadan et 
al., 2007b) and induce their apoptosis via a 
paracrine mechanism (Hwang et al., 2012). 
This effect is mediated through secretion of 
variable growth factors including HGF 
(Wang et al., 2009). HGF is a potent anti-
apoptotic mitotic promoter for hepatocytes, 
apoptotic promoter for HSCs (Chen et al., 
2013). It can also suppress HSC activity 
through downregulation of TGF-β1 (El-
Ansary et al., 2012) and can reduce gene ex-
pression of collagen type I and type III.  
In the current study there was a signifi-
cant reduction in relative expression of α-
SMA in both MSCs treated groups and a 
significant decrease in serum TGF-β1 after 
MSCs treatment which was more prominent 
in the differentiated MSCs group. This de-
cline in serum TGF-β1 may be attributed to 
the elimination of activated HSCs (Mormone 
et al., 2011) mediated by secretion of HGF 
from the transplanted MSCs (El-Ansary et 
al., 2012). 
We demonstrated a significant increase 
in MMP-2 gene expression following MSC 
therapy. On the contrary, TIMP-2 gene ex-
pression showed a significant decrease in 
both MSC-treated groups when compared to 
TAA group, which was more marked in the 
differentiated MSCs group. Increased MMP-
2 and decreased TIMP-2 led to an increase in 
the MMP-2/TIMP-2 ratio in MSC-treated 
groups. This increase may explain the re-
gression of liver fibrosis after MSC trans-
plantation in our study with augmentation of 
ECM degradation. We confirmed these re-
sults by the marked regression of fibrosis 
stage in both MSC-treated groups in compar-
ison with TAA groups especially the differ-
entiated MSCs group in which cirrhosis re-
gression was almost complete. This im-
provement clearly reflected in histopatholog-
ical findings which revealed nearly normal-
ised hepatic architecture in the differentiated 
MSCs group. 
Our results are consistent with studies by 
Zhao et al. (2012) who showed that bone 
marrow-derived MSCs were able to suppress 
CCl4 induced liver fibrosis through the high 
expression of MMP-2 and MMP-9. On the 
other hand, downregulation of TIMP-2 could 
be due to apoptosis and arrested activation 
and proliferation of HSCs by MSCs (as 
HSCs are its only source). 
Our results demonstrated a marked re-
duction in the relative expression of pro-
apoptotic marker Bax and a significant in-
crease in relative expression of anti-apoptotic 
marker Bcl2 following MSCs treatment. It 
was reported that MSCs secrete agonists that 
inhibit hepatocyte apoptosis (Mohsin et al., 
2011). 
MSCs also have multiple immunomodu-
latory effects. They can counteract inflam-
mation and inhibit the proliferation and func-
tion of the major immune cell populations, 
including T cells, B cells and NKCs (Shi et 
al., 2011). This anti-inflammatory action 
may explain the decreased necro-inflam-
matory reaction in MSC-treated groups 
demonstrated by our histopathological re-
sults. 
Our study showed the better outcome of 
partially differentiated MSCs to regress liver 
cirrhosis compared to undifferentiated 
MSCs. This impact was evident from the dif-
ference in histopathological results, which 
were almost normal and liver functions par-
ticularly serum albumin level, that was sig-
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nificantly higher in the differentiated MSCs 
group compared to the undifferentiated 
MSCs group. In agreement with our work, 
Oyagi et al. (2006) found that the transplan-
tation of HGF treated MSCs markedly im-
proved liver fibrosis in rats when compared 
with undifferentiated MSCs.  
Concerning HE, our results revealed an 
improvement in spatial memory after MSCs 
treatment which was more observable in the 
differentiated MSCs group. Also, there was a 
relative decrease in anxiogenic behavior in 
differentiated MSCs group but not in the un-
differentiated MSCs group. We supported 
our results by the histopathological findings. 
In the undifferentiated MSCs group, the hip-
pocampus shows the persistence of some 
features of the injury. On the other hand, dif-
ferentiated MSCs group showed relatively 
clearer signs of brain injury regression. 
Regression of liver cirrhosis after MSCs 
administration was mostly the cause of im-
provement of cognitive function in both 
MSCs groups. Liver cirrhosis induced hy-
perammonemia has the pivotal role in the 
neurotoxic effects of TAA (Mladenović et 
al., 2012), and we demonstrated that it is 
most probably the main cause of behavioral 
changes in the TAA group. Therefore, we 
suggest that the significant drop in serum 
ammonia level following MSCs treatment is 
the cause of improvement in cognitive func-
tions in the two MSCs groups. We suppose 
that the marked decrease in serum ammonia 
level decreased astrocytic swelling and resto-
ration of astrocytic function which revealed 
the significant increase in relative expression 
of GFAP after MSCs administration. Since 
our results showed that both types of MSCs 
undergone homing in the brain, even to a 
small extent, MSCs might have a direct role 
in the improvement of HE symptoms. An-
other proposed reason for improvement of 
spatial memory and anxiety after MSCs 
treatment is the significant increase in rela-
tive expression of D1 receptors in both 
MSCs groups when compared to TAA 
group. 
It is worth noting that although relative 
expression of GFAP, synaptophysin, and D1 
receptors increased significantly in both 
MSCs groups to nearly the same extent, spa-
tial memory improvement was more promi-
nent in the differentiated MSCs group com-
pared to the undifferentiated MSCs group. 
Also, anxiety symptoms were observed to be 
improved only in the differentiated MSCs 
group which needs further investigation. 
In conclusion, MSCs therapy could re-
generate cirrhotic liver, improve liver func-
tion and hepatic encephalopathy (HE) with 
hepatogenic partially differentiated MSCs 
are more efficient than undifferentiated 
MSCs. The superiority of partially differen-
tiated MSCs is most probably due to aug-
mented homing and differentiation abilities 
of these cells.  
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